The adult heart responds to excessive neurohumoral signaling and workload by a pathological growth response characterized by hypertrophy of cardiomyocytes and activation of a fetal program of cardiac gene expression. These responses culminate in diminished pump function, ventricular dilatation, wall thinning, and fibrosis, and can result in sudden death. Myocyte enhancer factor–2 (MEF2) transcription factors serve as targets of the signaling pathways that drive pathological cardiac remodeling, but the requirement for MEF2 factors in the progression of heart disease in vivo has not been determined. MEF2A and MEF2D are the primary MEF2 factors expressed in the adult heart. To specifically determine the role of MEF2D in pathological cardiac remodeling, we generated mice with a conditional MEF2D allele. MEF2D-null mice were viable, but were resistant to cardiac hypertrophy, fetal gene activation, and fibrosis in response to pressure overload and β-chronic adrenergic stimulation. Furthermore, we show in a transgenic mouse model that forced overexpression of MEF2D was sufficient to drive the fetal gene program and pathological remodeling of the heart. These results reveal a unique and important function for MEF2D in stress-dependent cardiac growth and reprogramming of gene expression in the adult heart.
Yuri Kim, Dillon Phan, Eva van Rooij, Da-Zhi Wang, John McAnally, Xiaoxia Qi, James A. Richardson, Joseph A. Hill, Rhonda Bassel-Duby, Eric N. Olson
Title and authors | Publication | Year |
---|---|---|
Temporal Transcriptomic Analysis of Periodontal Disease Progression and Its Molecular Links to Systemic Diseases
Nantakeeratipat T, Fujihara C, Takedachi M |
International Journal of Molecular Sciences | 2025 |
Resveratrol-Based Liposomes Improve Cardiac Remodeling Induced by Isoproterenol Partially by Modulating MEF2, Cytochrome C and S100A1 Expression.
Alhusaini AM, Alghibiwi HK, Sarawi WS, Alsaab JS, Alshehri SM, Alqahtani QH, Alshanwani AR, Aljassas EA, Alsultan EN, Hasan IH |
Dose-response : a publication of International Hormesis Society | 2024 |
The Molecular and Biological Function of MEF2D in Leukemia.
Zhang P, Lu R |
Advances in experimental medicine and biology | 2024 |
Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis
Gönczi M, Teixeira JM, Barrera-Vilarmau S, Mediani L, Antoniani F, Nagy TM, Fehér K, Ráduly Z, Ambrus V, Tőzsér J, Barta E, Kövér KE, Csernoch L, Carra S, Fuxreiter M |
Nature Communications | 2023 |
Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia
Chang N, Feng J, Liao P, Hu Y, Li M, He Y, Li Y |
Translational cancer research | 2023 |
Nuclear Calcium in Cardiac (Patho)Physiology: Small Compartment, Big Impact.
Kiessling M, Djalinac N, Voglhuber J, Ljubojevic-Holzer S |
Biomedicines | 2023 |
A family with brachydactyly mental retardation syndrome with a missense variant in HDAC4
Takeyari S, Yamamoto K, Fujiwara M, Ohata Y, Kitaoka T, Kubota T, Nagata M, Ishihara Y, Miyashita Y, Asano Y, Ozono K |
Clinical Pediatric Endocrinology | 2023 |
The MEF2A transcription factor interactome in cardiomyocytes.
Moustafa A, Hashemi S, Brar G, Grigull J, Ng SHS, Williams D, Schmitt-Ulms G, McDermott JC |
Cell Death and Disease | 2023 |
CRISPR activation and interference as investigative tools in the cardiovascular system
Carroll MS, Giacca M |
The International Journal of Biochemistry & Cell Biology | 2023 |
The significance of ERK5 catalytic-independent functions in disease pathways
Le NT |
Frontiers in Cell and Developmental Biology | 2023 |
HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction
Zhu C, Piao Z, Jin L |
Orphanet Journal of Rare Diseases | 2023 |
Aging, adaptation and maladaptation
Lissek T |
2023 | |
Transcriptome of Left Ventricle and Sinoatrial Node in Young and Old C57 Mice
Qu JH, Tarasov KV, Tarasova YS, Chakir K, Lakatta EG |
2023 | |
Loss of m6A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression
Y Han, T Du, S Guo, L Wang, G Dai, T Long, T Xu, X Zhuang, C Liu, S Li, D Zhang, X Liao, Y Dong, K Lui, X Tan, S Lin, Y Chen, Z Huang |
Frontiers in Cardiovascular Medicine | 2022 |
Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation
Zheng L, Wang J, Zhang R, Zhang Y, Geng J, Cao L, Zhao X, Geng J, Du X, Hu Y, Cong H |
Computational and mathematical methods in medicine | 2022 |
Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
Silva J, da Costa Martins PA |
Cells | 2022 |
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia
Harada T, Heshmati Y, Kalfon J, Perez MW, Xavier Ferrucio J, Ewers J, Hubbell Engler B, Kossenkov A, Ellegast JM, Yi JS, Bowker A, Zhu Q, Eagle K, Liu T, Kai Y, Dempster JM, Kugener G, Wickramasinghe J, Herbert ZT, Li CH, Vrabič Koren J, Weinstock DM, Paralkar VR, Nabet B, Lin CY, Dharia NV, Stegmaier K, Orkin SH, Pimkin M |
Genes & development | 2022 |
Rewiring of 3D Chromatin Topology Orchestrates Transcriptional Reprogramming and the Development of Human Dilated Cardiomyopathy
Feng Y, Cai L, Hong W, Zhang C, Tan N, Wang M, Wang C, Liu F, Wang X, Ma J, Gao C, Kumar M, Mo Y, Geng Q, Luo C, Lin Y, Chen H, Wang SY, Watson MJ, Jegga AG, Pedersen RA, Fu JD, Wang ZV, Fan GC, Sadayappan S, Wang Y, Pauklin S, Huang F, Huang W, Jiang L |
Circulation | 2022 |
Targeting mAKAPβ expression as a therapeutic approach for ischemic cardiomyopathy.
Martinez EC, Li J, Ataam JA, Tokarski K, Thakur H, Karakikes I, Dodge-Kafka K, Kapiloff MS |
Gene Therapy | 2022 |
Protections of transcription factor BACH2 and natural product myricetin against pathological cardiac hypertrophy and dysfunction.
Jiang X, Cao M, Wu J, Wang X, Zhang G, Yang C, Gao P, Zou Y |
Frontiers in physiology | 2022 |
Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia
Pingul BY, Huang H, Chen Q, Alikarami F, Zhang Z, Qi J, Bernt KM, Berger SL, Cao Z, Shi J |
iScience | 2022 |
Variable paralog expression underlies phenotype variation
Bailon-Zambrano R, Sucharov J, Mumme-Monheit A, Murry M, Stenzel A, Pulvino AT, Mitchell JM, Colborn KL, Nichols JT |
eLife | 2022 |
Inositol 1,4,5-trisphosphate receptors in cardiomyocyte physiology and disease
Demydenko K, Ekhteraei-Tousi S, Roderick HL |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2022 |
Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion
Zhang M, Zhang H, Li Z, Bai L, Wang Q, Li J, Jiang M, Xue Q, Cheng N, Zhang W, Mao D, Chen Z, Huang J, Meng G, Chen Z, Chen SJ |
Blood | 2022 |
Quercetin alleviates diastolic dysfunction and suppresses adverse pro-hypertrophic signaling in diabetic rats
Bartosova L, Horvath C, Galis P, Ferenczyova K, Kalocayova B, Szobi A, Duris-Adameova A, Bartekova M, Rajtik T |
Frontiers in Endocrinology | 2022 |
MEF2 (Myocyte Enhancer Factor 2) Is Essential for Endothelial Homeostasis and the Atheroprotective Gene Expression Program
YW Lu, N Martino, BD Gerlach, JM Lamar, PA Vincent, AP Adam, JJ Schwarz |
Arteriosclerosis, thrombosis, and vascular biology | 2021 |
The MEK5/ERK5 Pathway in Health and Disease
R Paudel, L Fusi, M Schmidt |
International journal of molecular sciences | 2021 |
Transcriptional Regulation of Postnatal Cardiomyocyte Maturation and Regeneration
SL Padula, N Velayutham, KE Yutzey |
International journal of molecular sciences | 2021 |
A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration
A Raso, E Dirkx, V Sampaio-Pinto, H el Azzouzi, RJ Cubero, DW Sorensen, L Ottaviani, S Olieslagers, MM Huibers, R de Weger, S Siddiqi, S Moimas, C Torrini, L Zentillin, L Braga, DS Nascimento, PA da Costa Martins, JH van Berlo, S Zacchigna, M Giacca, LJ Windt |
Nature Communications | 2021 |
Mef2d sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity
Eros Di Giorgio, Liqing Wang, Yan Xiong, Tatiana Akimova, Lanette M. Christensen, Rongxiang Han, Arabinda Samanta, Matteo Trevisanut, Tricia R. Bhatti, Ulf H. Beier, Wayne W. Hancock |
Journal of Clinical Investigation | 2020 |
MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure
AH Pereira, AC Cardoso, SR Consonni, RR Oliveira, A Saito, ML Vaggione, JR Matos-Souza, MF Carazzolle, A Gonçalves, JL Fernandes, GC Ribeiro, MM Lopes, JD Molkentin, KG Franchini |
EBioMedicine | 2020 |
Genomic Binding Patterns of Forkhead Box Protein O1 Reveal its Unique Role in Cardiac Hypertrophy
J Pfleger, RC Coleman, J Ibetti, R Roy, ID Kyriazis, E Gao, K Drosatos, WJ Koch |
Circulation | 2020 |
Loss of Mef2D function enhances TLR induced IL-10 production in macrophages
MJ Pattison, RJ Naik, KM Reyskens, JS Arthur |
Bioscience Reports | 2020 |
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
S Batkai, C Genschel, J Viereck, S Rump, C Bär, T Borchert, D Traxler, M Riesenhuber, A Spannbauer, D Lukovic, K Zlabinger, E Hašimbegović, J Winkler, R Garamvölgyi, S Neitzel, M Gyöngyösi, T Thum |
European Heart Journal | 2020 |
MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury
X Xia, CY Yu, M Bian, CB Sun, B Tanasa, KC Chang, DM Bruffett, H Thakur, SH Shah, C Knasel, EG Cameron, MS Kapiloff, JL Goldberg, TC Badea |
PloS one | 2020 |
Nuclear receptor corepressor 1 represses cardiac hypertrophy
C Li, XN Sun, BY Chen, MR Zeng, LJ Du, T Liu, HH Gu, Y Liu, YL Li, LJ Zhou, XJ Zheng, YY Zhang, WC Zhang, Y Liu, C Shi, S Shao, XR Shi, Y Yi, X Liu, J Wang, J Auwerx, ZV Wang, F Jia, RG Li, SZ Duan |
EMBO Molecular Medicine | 2019 |
MEF2 and the Right Ventricle: From Development to Disease
KR Clapham, I Singh, IS Capuano, S Rajagopal, HJ Chun |
Frontiers in Cardiovascular Medicine | 2019 |
The lipid-droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4
ZH Jebessa, KD Shanmukha, M Dewenter, LH Lehmann, C Xu, F Schreiter, D Siede, XM Gong, BC Worst, G Federico, SW Sauer, T Fischer, L Wechselberger, OJ Müller, S Sossalla, C Dieterich, P Most, HJ Gröne, C Moro, M Oberer, G Haemmerle, HA Katus, J Tyedmers, J Backs |
2019 | |
MEF-2 isoforms’ (A-D) roles in development and tumorigenesis
K Madugula, R Mulherkar, ZK Khan, DG Chigbu, D Patel, EW Harhaj, P Jain |
Oncotarget | 2019 |
Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice
JA Mohawk, KH Cox, M Sato, SH Yoo, M Yanagisawa, EN Olson, JS Takahashi |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2019 |
mAKAPβ signalosomes – A nodal regulator of gene transcription associated with pathological cardiac remodeling
K Dodge-Kafka, M Gildart, K Tokarski, MS Kapiloff |
Cellular Signalling | 2019 |
Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure
DF Dai, Y Liu, N Basisty, P Karunadharma, SG Dastidar, YA Chiao, T Chen, RP Beyer, MT Chin, M Maccoss, AR Spada, PS Rabinovitch |
GeroScience | 2019 |
Regulation of cardiomyocyte maturation during critical perinatal window
S Kannan, C Kwon |
The Journal of Physiology | 2019 |
Waking the sleeping dragon: gene expression profiling reveals adaptive strategies of the hibernating reptile Pogona vitticeps
A Capraro, D OMeally, SA Waters, HR Patel, A Georges, PD Waters |
BMC Genomics | 2019 |
Cardiac function modulation depends on the A‐kinase anchoring protein complex
YR Zhu, XX Jiang, Y Zheng, J Xiong, D Wei, DM Zhang |
Journal of Cellular and Molecular Medicine | 2019 |
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function
A Wnorowski, A Sharma, H Chen, H Wu, NY Shao, N Sayed, C Liu, S Countryman, LS Stodieck, KH Rubins, SM Wu, PH Lee, JC Wu |
Stem Cell Reports | 2019 |
Inflammation leads through PGE/EP 3 signaling to HDAC5/MEF2‐dependent transcription in cardiac myocytes
AD Tóth, R Schell, M Lévay, C Vettel, P Theis, C Haslinger, F Alban, S Werhahn, L Frischbier, J KrebsHaupenthal, D Thomas, HJ Gröne, M Avkiran, HA Katus, T Wieland, J Backs |
EMBO Molecular Medicine | 2018 |
Morphology regulation in vascular endothelial cells
K Tsuji-Tamura, M Ogawa |
Inflammation and Regeneration | 2018 |
Network-based predictions of in vivo cardiac hypertrophy
DU Frank, MD Sutcliffe, JJ Saucerman |
Journal of Molecular and Cellular Cardiology | 2018 |
Physiological Responses to Swimming-Induced Exercise in the Adult Zebrafish Regenerating Heart
M Rovira, DM Borràs, IJ Marques, C Puig, JV Planas |
Frontiers in physiology | 2018 |
Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
S Nomura, M Satoh, T Fujita, T Higo, T Sumida, T Ko, T Yamaguchi, T Tobita, AT Naito, M Ito, K Fujita, M Harada, H Toko, Y Kobayashi, K Ito, E Takimoto, H Akazawa, H Morita, H Aburatani, I Komuro |
Nature Communications | 2018 |
Muscle A-kinase–anchoring protein-β–bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D
J Li, SA Paris, H Thakur, MS Kapiloff, KL Dodge-Kafka |
The Journal of biological chemistry | 2018 |
Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure
Duane Hall, Jessica Ponce, Biyi Chen, Kathryn Spitler, Adrianne Alexia, Gavin Oudit, Long-sheng Song, Chad Grueter |
JCI Insight | 2017 |
Reversal of pathological cardiac hypertrophy via the MEF2-co-regulator interface
Jian Qin Wei, Shaurya Joshi, Svetlana Speransky, Christopher Crowley, Nimanthi Jayathilaka, Xiao Lei, Yongqing Wu, David Gai, Sumit Jain, Michael Hoosien, Yan Gao, Lin Chen, Nanette H. Bishopric |
JCI Insight | 2017 |
Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling
W Liu, A Ruiz-Velasco, S Wang, S Khan, M Zi, A Jungmann, MD Camacho-Muñoz, J Guo, G Du, L Xie, D Oceandy, A Nicolaou, G Galli, OJ Müller, EJ Cartwright, Y Ji, X Wang |
Nature Communications | 2017 |
A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway
LH Lehmann, ZH Jebessa, MM Kreusser, A Horsch, T He, M Kronlage, M Dewenter, V Sramek, U Oehl, J Krebs-Haupenthal, AH von der Lieth, A Schmidt, Q Sun, J Ritterhoff, D Finke, M Völkers, A Jungmann, SW Sauer, C Thiel, A Nickel, M Kohlhaas, M Schäfer, C Sticht, C Maack, N Gretz, M Wagner, A El-Armouche, LS Maier, JE Londoño, B Meder, M Freichel, HJ Gröne, P Most, OJ Müller, S Herzig, EE Furlong, HA Katus, J Backs |
Nature Medicine | 2017 |
Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
SW Tobin, S Hashemi, K Dadson, S Turdi, K Ebrahimian, J Zhao, G Sweeney, J Grigull, JC McDermott |
Scientific Reports | 2017 |
Z-disc protein CHAPb induces cardiomyopathy and contractile dysfunction in the postnatal heart
W Eldik, B Adel, J Monshouwer-Kloots, D Salvatori, S Maas, I der Made, EE Creemers, D Frank, N Frey, N Boontje, J der Velden, P Steendijk, C Mummery, R Passier, A Beqqali, V Lionetti |
PloS one | 2017 |
Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice
ZQ Hu, JF Luo, XJ Yu, JN Zhu, L Huang, J Yang, YH Fu, T Li, YM Xue, YQ Feng, ZX Shan |
Oncotarget | 2017 |
Long-term consequences of disrupting adenosine signaling during embryonic development
SA Rivkees, CC Wendler |
Molecular Aspects of Medicine | 2017 |
MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress
S Nagar, SM Noveral, D Trudler, KM Lopez, SR McKercher, X Han, JR Yates, JC Piña-Crespo, N Nakanishi, T Satoh, S Okamoto, SA Lipton |
Proceedings of the National Academy of Sciences | 2017 |
Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors
CA Desjardins, FJ Naya |
The Journal of biological chemistry | 2017 |
Poly(A) tail length regulates PABPC1 expression to tune translation in the heart
S Chorghade, J Seimetz, R Emmons, J Yang, SM Bresson, MD Lisio, G Parise, NK Conrad, A Kalsotra |
eLife | 2017 |
Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency
S Nagar, D Trudler, SR McKercher, J Piña-Crespo, N Nakanishi, SI Okamoto, SA Lipton |
Investigative ophthalmology & visual science | 2017 |
Protein kinase D2: a versatile player in cancer biology
N Azoitei, M Cobbaut, A Becher, JV Lint, T Seufferlein |
Oncogene | 2017 |
How cardiomyocytes sense pathophysiological stresses for cardiac remodeling
ZK Haque, DZ Wang |
Cellular and Molecular Life Sciences | 2016 |
Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy
CM Tang, F Liu, JN Zhu, YH Fu, QX Lin, CY Deng, ZQ Hu, H Yang, XL Zheng, JD Cheng, SL Wu, ZX Shan |
Scientific Reports | 2016 |
The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming
C Desjardins, F Naya |
Journal of Cardiovascular Development and Disease | 2016 |
Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment
JW Wassenaar, R Gaetani, JJ Garcia, RL Braden, CG Luo, D Huang, AN DeMaria, JH Omens, KL Christman |
Journal of the American College of Cardiology | 2016 |
ERK5 and Cell Proliferation: Nuclear Localization Is What Matters
N Gomez, T Erazo, JM Lizcano |
Frontiers in Cell and Developmental Biology | 2016 |
In Utero Caffeine Exposure Induces Transgenerational Effects on the Adult Heart
X Fang, RR Poulsen, SA Rivkees, CC Wendler |
Scientific Reports | 2016 |
miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy
AL Clark, S Maruyama, S Sano, A Accorsi, M Girgenrath, K Walsh, FJ Naya, M Karmazyn |
PloS one | 2016 |
Readers, Writers, and Erasers: Chromatin as the Whiteboard of Heart Disease
TG Gillette, JA Hill |
Circulation research | 2015 |
Executioner Caspase-3 and 7 Deficiency Reduces Myocyte Number in the Developing Mouse Heart
M Cardona, JA López, A Serafín, A Rongvaux, J Inserte, D García-Dorado, R Flavell, M Llovera, X Cañas, J Vázquez, D Sanchis, GC Fan |
PloS one | 2015 |
Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers
S Hashemi, J Salma, S Wales, JC McDermott |
Cell Death Discovery | 2015 |
mAKAP—A Master Scaffold for Cardiac Remodeling:
CL Passariello, J Li, K Dodge-Kafka, MS Kapiloff |
Journal of Cardiovascular Pharmacology | 2015 |
MEF2D Drives Photoreceptor Development through a Genome-wide Competition for Tissue-Specific Enhancers
MM Andzelm, TJ Cherry, DA Harmin, AC Boeke, C Lee, M Hemberg, B Pawlyk, AN Malik, SW Flavell, MA Sandberg, E Raviola, ME Greenberg |
Neuron | 2015 |
Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy
KR Johnson, J Nicodemus-Johnson, MJ Spindler, GK Carnegie, S Gupta |
PloS one | 2015 |
MEF2D Deficiency in Neonatal Cardiomyocytes Triggers Cell Cycle Re-entry and Programmed Cell Death in Vitro
NL Estrella, AL Clark, CA Desjardins, SE Nocco, FJ Naya |
The Journal of biological chemistry | 2015 |
A p38 MAPK regulated MEF2:β-catenin interaction enhances canonical Wnt signalling
S Ehyai, MG Dionyssiou, JW Gordon, D Williams, KW Siu, JC McDermott |
Molecular and cellular biology | 2015 |
Inducible knockout of Mef2a, -c, and -d from nestin-expressing stem/progenitor cells and their progeny unexpectedly uncouples neurogenesis and dendritogenesis in vivo
SE Latchney, Y Jiang, DP Petrik, AJ Eisch, J Hsieh |
The FASEB Journal | 2015 |
Novel Targets for the Transcription Factors MEF2 in MA-10 Leydig Cells
M Di-Luoffo, C Daems, F Bergeron, JJ Tremblay |
Biology of reproduction | 2015 |
MEF2 transcription factors: developmental regulators and emerging cancer genes
Pon JR, Marra MA |
Oncotarget | 2015 |
The Scaffold Protein Muscle A-Kinase Anchoring Protein Orchestrates Cardiac Myocyte Hypertrophic Signaling Required for the Development of Heart Failure
MD Kritzer, J Li, CL Passariello, M Gayanilo, H Thakur, J Dayan, K Dodge-Kafka, MS Kapiloff |
Circulation. Heart failure | 2014 |
CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury
M Weinreuter, MM Kreusser, J Beckendorf, FC Schreiter, F Leuschner, LH Lehmann, KP Hofmann, JS Rostosky, N Diemert, C Xu, HC Volz, A Jungmann, A Nickel, C Sticht, N Gretz, C Maack, MD Schneider, HJ Grone, OJ Muller, HA Katus, J Backs |
EMBO Molecular Medicine | 2014 |
Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling
LH Lehmann, JS Rostosky, SJ Buss, MM Kreusser, J Krebs, W Mier, F Enseleit, K Spiger, SE Hardt, T Wieland, M Haass, TF Luscher, MD Schneider, R Parlato, HJ Grone, U Haberkorn, M Yanagisawa, HA Katus, J Backs |
Proceedings of the National Academy of Sciences | 2014 |
Cardiac CaM Kinase II Genes and Contribute to Adverse Remodeling but Redundantly Inhibit Calcineurin-Induced Myocardial Hypertrophy
MM Kreusser, LH Lehmann, S Keranov, MO Hoting, U Oehl, M Kohlhaas, JC Reil, K Neumann, MD Schneider, JA Hill, D Dobrev, C Maack, LS Maier, HJ Grone, HA Katus, EN Olson, J Backs |
Circulation | 2014 |
Requirement of MEF2A, C, and D for skeletal muscle regeneration
N Liu, BR Nelson, S Bezprozvannaya, JM Shelton, JA Richardson, R Bassel-Duby, EN Olson |
Proceedings of the National Academy of Sciences | 2014 |
Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling
S Wales, S Hashemi, A Blais, JC McDermott |
Nucleic Acids Research | 2014 |
ATM-Dependent Phosphorylation of MEF2D Promotes Neuronal Survival after DNA Damage
SF Chan, S Sances, LM Brill, S Okamoto, R Zaidi, SR McKercher, MW Akhtar, N Nakanishi, SA Lipton |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2014 |
Interferon Regulatory Factor 7 Functions as a Novel Negative Regulator of Pathological Cardiac HypertrophyNovelty and Significance
DS Jiang, Y Liu, H Zhou, Y Zhang, XD Zhang, XF Zhang, K Chen, L Gao, J Peng, H Gong, Y Chen, Q Yang, PP Liu, GC Fan, Y Zou, H Li |
Hypertension | 2014 |
Comparative analysis reveals distinct and overlapping functions of Mef2c and Mef2d during cardiogenesis in Xenopus laevis
Y Guo, SJ Kühl, AS Pfister, W Cizelsky, S Denk, L Beer-Molz, M Kühl |
PloS one | 2014 |
Steroid Receptor Coactivator-2 Is a Dual Regulator of Cardiac Transcription Factor Function
EL Reineke, A Benham, B Soibam, E Stashi, H Taegtmeyer, ML Entman, RJ Schwartz, BW O'Malley |
The Journal of biological chemistry | 2014 |
MEF2 Is Restricted to the Male Gonad and Regulates Expression of the Orphan Nuclear Receptor NR4A1
C Daems, LJ Martin, C Brousseau, JJ Tremblay |
Molecular Endocrinology | 2014 |
Histone deacetylase signaling in cardioprotection
LH Lehmann, BC Worst, DA Stanmore, J Backs |
Cellular and Molecular Life Sciences | 2013 |
Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy
H Chen, X Wang, M Tong, D Wu, S Wu, J Chen, X Wang, X Wang, Y Kang, H Tang, C Tang, W Jiang |
PloS one | 2013 |
Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy
DS Jiang, ZY Bian, Y Zhang, SM Zhang, Y Liu, R Zhang, Y Chen, Q Yang, XD Zhang, GC Fan, H Li |
Hypertension | 2013 |
Postsynaptic FMRP bidirectionally regulates excitatory synapses as a function of developmental age and MEF2 activity
T Zang, MA Maksimova, CW Cowan, R Bassel-Duby, EN Olson, KM Huber |
Molecular and Cellular Neuroscience | 2013 |
A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart
J Ye, M Llorian, M Cardona, A Rongvaux, RS Moubarak, JX Comella, R Bassel-Duby, RA Flavell, EN Olson, CW Smith, D Sanchis |
Journal of cell science | 2013 |
Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
P Teekakirikul, RF Padera, JG Seidman, CE Seidman |
The Journal of Cell Biology | 2012 |
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth
FM Drawnel, CR Archer, HL Roderick |
British Journal of Pharmacology | 2012 |
In Vivo Analysis of MEF2 Transcription Factors in Synapse Regulation and Neuronal Survival
MW Akhtar, MS Kim, M Adachi, MJ Morris, X Qi, JA Richardson, R Bassel-Duby, EN Olson, ET Kavalali, LM Monteggia |
PloS one | 2012 |
Regulation of MEF2 Transcriptional Activity by Calcineurin/mAKAP Complexes
J Li, MA Vargas, MS Kapiloff, KL Dodge-Kafka |
Experimental Cell Research | 2012 |
Functional and mechanistic exploration of an adult neurogenesis-promoting small molecule
D Petrik, Y Jiang, SG Birnbaum, CM Powell, MS Kim, J Hsieh, AJ Eisch |
The FASEB Journal | 2012 |
Direct Regulation of Complex I by Mitochondrial MEF2D and Its Role in Mouse Model and Human Specimens of Parkinson’s Disease
Hua She, Qian Yang, Kennie Shepherd, Yoland Smith, Gary Miller, Claudia Testa, Zixu Mao |
Journal of Clinical Investigation | 2011 |
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4
J Backs, BC Worst, LH Lehmann, DM Patrick, Z Jebessa, MM Kreusser, Q Sun, L Chen, C Heft, HA Katus, EN Olson |
The Journal of Cell Biology | 2011 |
Oxidation of CaMKII determines cardiotoxic effects of aldosterone
BJ He, ML Joiner, MV Singh, ED Luczak, PD Swaminathan, OM Koval, W Kutschke, C Allamargot, J Yang, X Guan, K Zimmerman, IM Grumbach, RM Weiss, DR Spitz, CD Sigmund, WM Blankesteijn, S Heymans, PJ Mohler, ME Anderson |
Nature Medicine | 2011 |
The Mef2A Transcription Factor Coordinately Regulates a Costamere Gene Program in Cardiac Muscle*
EP Ewen, CM Snyder, M Wilson, D Desjardins, FJ Naya |
The Journal of biological chemistry | 2011 |
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy
G Majumdar, RJ Rooney, IM Johnson, R Raghow |
Physiological genomics | 2011 |
Hadp1, a newly identified pleckstrin homology domain protein, is required for cardiac contractility in zebrafish
JD Wythe, MJ Jurynec, LD Urness, CA Jones, MK Sabeh, AA Werdich, M Sato, HJ Yost, DJ Grunwald, CA MacRae, DY Li |
Disease models & mechanisms | 2011 |
Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly
J He, J Ye, Y Cai, C Riquelme, JO Liu, X Liu, A Han, L Chen |
Nucleic Acids Research | 2011 |
Sex-dimorphism in Cardiac Nutrigenomics: effect of Trans fat and/or Monosodium Glutamate consumption
KS Collison, MZ Zaidi, Z Maqbool, SM Saleh, A Inglis, NJ Makhoul, R Bakheet, M Shoukri, FA Al-Mohanna |
BMC Genomics | 2011 |
Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress
DF Dai, EJ Hsieh, Y Liu, T Chen, RP Beyer, MT Chin, MJ MacCoss, PS Rabinovitch |
Cardiovascular Research | 2011 |
Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth
I Kehat, J Davis, M Tiburcy, F Accornero, MK Saba-El-Leil, M Maillet, AJ York, JN Lorenz, WH Zimmermann, S Meloche, JD Molkentin |
Circulation research | 2011 |
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy
T Konno, D Chen, L Wang, H Wakimoto, P Teekakirikul, M Nayor, M Kawana, S Eminaga, JM Gorham, K Pandya, O Smithies, FJ Naya, EN Olson, JG Seidman, CE Seidman |
Proceedings of the National Academy of Sciences | 2010 |
Bone marrow support of the heart in pressure overload is lost with aging
NA Sopko, BA Turturice, ME Becker, CR Brown, F Dong, ZB Popović, MS Penn |
PloS one | 2010 |
Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the Heart
TE Kimura, J Jin, M Zi, S Prehar, W Liu, D Oceandy, J Abe, L Neyses, AH Weston, EJ Cartwright, X Wang |
Circulation research | 2010 |
The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload
Y Liu, M Yu, L Wu, MT Chin |
American journal of physiology. Heart and circulatory physiology | 2010 |
Active Wnt signaling in response to cardiac injury
MI Oerlemans, MJ Goumans, B Middelaar, H Clevers, PA Doevendans, JP Sluijter |
Basic Research in Cardiology | 2010 |
Structure of the MADS-box/MEF2 Domain of MEF2A Bound to DNA and Its Implication for Myocardin Recruitment
Y Wu, R Dey, A Han, N Jayathilaka, M Philips, J Ye, L Chen |
Journal of Molecular Biology | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice
AH Pereira, CF Clemente, AC Cardoso, TH Theizen, SA Rocco, CC Judice, MC Guido, VD Pascoal, I Lopes-Cendes, JR Souza, KG Franchini |
PloS one | 2009 |
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
M Haberland, RL Montgomery, EN Olson |
Nature reviews. Genetics | 2009 |
The isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload
J Backs, T Backs, S Neef, MM Kreusser, LH Lehmann, DM Patrick, CE Grueter, X Qi, JA Richardson, JA Hill, HA Katus, R Bassel-Duby, LS Maier, EN Olson |
Proceedings of the National Academy of Sciences | 2009 |
Evidence for Coregulation of Myocardial Gene Expression by MEF2 and NFAT in Human Heart Failure
ME Putt, S Hannenhalli, Y Lu, P Haines, HR Chandrupatla, EE Morrisey, KB Margulies, TP Cappola |
Circulation. Cardiovascular genetics | 2009 |
Maintenance of cardiac energy metabolism by histone deacetylase 3
Rusty L. Montgomery1, Matthew J. Potthoff1, Michael Haberland1, Xiaoxia Qi1, Satoshi Matsuzaki2, Kenneth M. Humphries2, James A. Richardson3, Rhonda Bassel-Duby1, and Eric N. Olson1 |
Journal of Clinical Investigation | 2008 |
The rationale for cardiomyocyte resuscitation in myocardial salvage
GW Dorn, A Diwan |
Journal of Molecular Medicine | 2008 |
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart
N Liu, S Bezprozvannaya, AH Williams, X Qi, JA Richardson, R Bassel-Duby, EN Olson |
Genes & development | 2008 |
Requirement of protein kinase D1 for pathological cardiac remodeling
J Fielitz, MS Kim, JM Shelton, X Qi, JA Hill, JA Richardson, R Bassel-Duby, EN Olson |
Proceedings of the National Academy of Sciences | 2008 |
Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure
DR Fermin, A Barac, S Lee, SP Polster, S Hannenhalli, TL Bergemann, S Grindle, DB Dyke, F Pagani, LW Miller, S Tan, C dos Remedios, TP Cappola, KB Margulies, JL Hall |
Circulation. Cardiovascular genetics | 2008 |
An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133
N Liu, AH Williams, Y Kim, J McAnally, S Bezprozvannaya, LB Sutherland, JA Richardson, R Bassel-Duby, EN Olson |
Proceedings of the National Academy of Sciences | 2007 |